Email this article Functional state of the liver and endothelium in patients with menopausal metabolic syndrome
- Authors: Bulatova I.A.1, Shevlyukova T.P.2, Gulyaeva I.L.1, Sobol A.A.1,3, Khasanova V.V.2
-
Affiliations:
- Vagner Perm State Medical University
- Tyumen State Medical University
- Women's Health Clinic
- Issue: Vol 26, No 2 (2024)
- Pages: 185-190
- Section: ORIGINAL ARTICLE
- URL: https://journal-vniispk.ru/2079-5831/article/view/257894
- DOI: https://doi.org/10.26442/20795696.2024.2.202757
- ID: 257894
Cite item
Full Text
Abstract
Aim. To assess the functional state of the liver and endothelium in patients with menopausal metabolic syndrome, depending on the degree of obesity.
Materials and methods. 70 patients with menopausal metabolic syndrome and obesity of varying degrees with an average age of 49.9±1.1 years and 30 practically healthy women without obesity and liver pathology with an average age of 47.3±2.6 years (comparison group) who were in the early postmenopausal period were examined. All women underwent biometric and laboratory-instrumental examination, including assessment of biometric indicators, determination of estradiol levels in the blood, biochemical markers of cytolysis and cholestasis, markers of endothelial dysfunction, assessment of microvascular tone reaction with calculation of the thermal vasodilation index, ultrasound examination of the liver and calculation of the Hepatic steatosis index (HSI).
Results. All patients with menopausal metabolic syndrome had a genoid type of obesity and hypoestrogenism. The level of estradiol decreased more significantly during the transition to the 1st degree of obesity (p=0.001). According to ultrasound and the HSI index, signs of liver steatosis were found in all patients with menopausal metabolic syndrome. Functional liver tests were within the reference values, 13% had an increase in the level of alkaline phosphatase, more significant in the group with grade 3 obesity (p=0.034). Laboratory markers of endothelial dysfunction were significantly higher in patients with menopausal metabolic syndrome than in the comparison group. The muscular and neurogenic index of thermal vasodilation significantly decreased in women with grade 1 obesity compared to the group with “pre-obesity“ (p=0.041 and 0.047). The lowest endothelial response was observed at the transition to the 1st degree of obesity in comparison with women with excess body weight.
Conclusion. For patients with menopausal metabolic syndrome to assess the condition of the liver, it is recommended to conduct a comprehensive instrumental laboratory examination, including ultrasound examination of the liver, biochemical parameters and calculation of the steatosis index.
Full Text
##article.viewOnOriginalSite##About the authors
Irina A. Bulatova
Vagner Perm State Medical University
Author for correspondence.
Email: bula.1977@mail.ru
ORCID iD: 0000-0002-7802-4796
D. Sci. (Med.), Vagner Perm State Medical University
Russian Federation, PermTatyana P. Shevlyukova
Tyumen State Medical University
Email: tata21.01@mail.ru
ORCID iD: 0000-0002-7019-6630
D. Sci. (Med.), Tyumen State Medical University
Russian Federation, TyumenInna L. Gulyaeva
Vagner Perm State Medical University
Email: pimenova774@yandex.ru
ORCID iD: 0000-0001-7521-1732
D. Sci. (Med.), Vagner Perm State Medical University
Russian Federation, PermAlexander A. Sobol
Vagner Perm State Medical University; Women's Health Clinic
Email: profdobro@gmail.com
laboratory assistant, Vagner Perm State Medical University, gastroenterologist, Women's Health Clinic
Russian Federation, Perm; PermValentina V. Khasanova
Tyumen State Medical University
Email: malofeeva-vv@yandex.ru
ORCID iD: 0000-0002-3764-5086
Cand. Sci. (Med.), Tyumen State Medical University
Russian Federation, TyumenReferences
- Баранова Е.И., Большакова О.О. Метаболический сердечно-сосудистый синдром в постменопаузе. Обзоры клинической кардиологии. 2005;1:2-11 [Baranova EI, Bol'shakova OO. Metabolic cardiovascular syndrome in postmenopause. Reviews of the Clinical Kardiologii. 2005;1:2-11 (in Russian)].
- Серов В.Н., Прилепская В.Н., Овсянникова Т.В. Гинекологическая эндокринология. М.: МЕДпресс-информ, 2004 [Serov VN, Prilepskaia VN, Ovsiannikova TV. Gynekologicheskaia endokrinologiia. Moscow: MEDpress-inform, 2004 (in Russian)].
- Giannini A, Caretto М, Genazzani AR, Simoncini Т. Menopause, Hormone Replacement Therapy (HRT) and Obesity. Curre Res Diabetes and Obes J. 2018;7(1):555704.
- Сметанин М.Ю., Пименов Л.Т., Пименова Л.И. Клинико-функциональное состояние печени при менопаузальном метаболическом синдроме. Практическая медицина. 2010;4(10). Режим доступа: http://pmarchive.ru/kliniko-funkcionalnoe-sostoyanie-pecheni-pri-menopauzalnom-metabolicheskom-sindrome/ Ссылка активна на 15.02.2023 [Smetanin MJ, Pimenov LT, Pimenova LI. Clinical and functional state of the liver in menopausal metabolic syndrome. Prakticheskaia Meditsina. 2010;4(10). Available at: http://pmarchive.ru/kliniko-funkcionalnoe-sostoyanie-pecheni-pri-menopauzalnom-metabolicheskom-sindrome/ Accessed: 15.02.2023 (in Russian)].
- Сандакова, Е.А., Жуковская И.Г. Особенности течения периода менопаузального перехода и ранней постменопаузы у женщин с различными типами и степенью ожирения. РМЖ. Мать и дитя. 2019;1:16-22 [Sandakova EA, Zhukovskaya IG. Features of the course of the menopausal transition and early postmenopause in women with different types and degrees of obesity. RMZh. Mat' i ditia. 2019;1:16-22 (in Russian)].
- Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202-9.
- Маевская М.В., Котовская Ю.В., Ивашкин В.Т., и др. Национальный Консенсус для врачей по ведению взрослых пациентов с неалкогольной жировой болезнью печени и ее основными коморбидными состояниями. Терапевтический архив. 2022;94(2):216-53 [Maevskaya MV, Kotovskaya YuV, Ivashkin VT, et al. National Consensus for physicians on the management of adult patients with non-alcoholic fatty liver disease and its main comorbid conditions. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(2):216-53 (in Russian)].
- Тарасова Л.В., Цыганова Ю.В., Опалинская И.В., и др. Обзор методов лабораторной диагностики, применяемых при неалкогольной жировой болезни печени (НАЖБП) и алкогольной болезни печени (АБП) на современном этапе. Экспериментальная и клиническая гастроэнтерология. 2019;164(4):72-7 [Tarasova LV, Tsyganova YuV, Opalinskaya IV, et al. Review of laboratory diagnostic methods used in non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ABP) at the present stage. Eksperimental'naia i Klinicheskaia Gastroenterologiia. 2019;164(4):72-7 (in Russian)].
- Смирнова Е.Н., Шулькина С.Г. Содержание лептина, растворимых рецепторов лептина и индекса свободного лептина у больных с метаболическим синдромом. Ожирение и метаболизм. 2017;14(1):30-4 [Smirnova EN, Shul'kina SG. The content of leptin, soluble leptin receptors and free leptin index in patients with metabolic syndrome. Ozhirenie i Metabolizm. 2017;14(1):30-4 (in Russian)].
- Ковалева Ю.В. Гормоны жировой ткани и их роль в формировании гормонального статуса и патогенезе метаболических нарушений у женщин. Артериальная гипертензия. 2015;21(4):356-70 [Kovaleva YuV. Adipose tissue hormones and their role in the formation of hormonal status and pathogenesis of metabolic disorders in women. Arterial'naia gipertenziia. 2015;21(4):356-70 (in Russian)].
- Тирикова О.В., Козлова Н.М., Елисеев С.М., и др. Эндотелиальная дисфункция у пациентов с неалкогольной жировой болезнью печени. Экспериментальная и клиническая гастроэнтерология. 2022;7:45-53 [Tirikova OV, Kozlova NM, Eliseev SM, et al. Endothelial dysfunction in patients with non-alcoholic fatty liver disease. Eksperimental'naia i Klinicheskaia Gastroenterologiia. 2022;7:45-53 (in Russian)].
- Петрищев Н.Н., Васина Л.В., Власов Т.Д. Эндотелиальная дисфункция и ее основные маркеры. Региональное кровообращение и микроциркуляция. 2017;1(61):4-15 [Petrishchev NN, Vasina LV, Vlasov TD. Endothelial dysfunction and its main markers. Regional'noe Krovoobrashchenie i Mikrotsirkuliatsiia. 2017;1(61):4-15 (in Russian)].
- Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Digestive Liver Dis. 2010;42:503-8.
- Florentino GSA, Cotrim HP, Vilar CP, et al. Nonalcoholic fatty liver disease in menopausal women. Arq Gastroenterol. 2013;50(3):180-5.
- Klair JS, Yang JD, Abdelmalek MF, et al. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology. 2016;64(1):85-91.
- Ballestri S, Zona S, Targher G, et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(5):936-44.
- Кривошеев А.Б., Куимов А.Д., Богорянова П.А. и др. Клинические и метаболические особенности неалкогольной жировой болезни печени у мужчин и женщин. Терапевтический архив. 2017;89(2):45-51 [Krivosheev AB, Kuimov AD, Bogoryanova PA, et al. Clinical and metabolic features of non-alcoholic fatty liver disease in men and women. Terapevticheskii Arkhiv (Ter. Arkh.). 2017;89(2):45-51 (in Russian)].
Supplementary files
